scholarly journals Aging Affects the Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy

PLoS ONE ◽  
2012 ◽  
Vol 7 (12) ◽  
pp. e51238 ◽  
Author(s):  
Charlotte Suetta ◽  
Ulrik Frandsen ◽  
Line Jensen ◽  
Mette Munk Jensen ◽  
Jakob G. Jespersen ◽  
...  
2017 ◽  
Vol 312 (5) ◽  
pp. E394-E406 ◽  
Author(s):  
Samuel Lee ◽  
Teresa C. Leone ◽  
Lisa Rogosa ◽  
John Rumsey ◽  
Julio Ayala ◽  
...  

Peroxisome proliferator-activated receptor-γ coactivator (PGC)-1α and -1β serve as master transcriptional regulators of muscle mitochondrial functional capacity and are capable of enhancing muscle endurance when overexpressed in mice. We sought to determine whether muscle-specific transgenic overexpression of PGC-1β affects the detraining response following endurance training. First, we established and validated a mouse exercise-training-detraining protocol. Second, using multiple physiological and gene expression end points, we found that PGC-1β overexpression in skeletal muscle of sedentary mice fully recapitulated the training response. Lastly, PGC-1β overexpression during the detraining period resulted in partial prevention of the detraining response. Specifically, an increase in the plateau at which O2 uptake (V̇o2) did not change from baseline with increasing treadmill speed [peak V̇o2 (ΔV̇o2max)] was maintained in trained mice with PGC-1β overexpression in muscle 6 wk after cessation of training. However, other detraining responses, including changes in running performance and in situ half relaxation time (a measure of contractility), were not affected by PGC-1β overexpression. We conclude that while activation of muscle PGC-1β is sufficient to drive the complete endurance phenotype in sedentary mice, it only partially prevents the detraining response following exercise training, suggesting that the process of endurance detraining involves mechanisms beyond the reversal of muscle autonomous mechanisms involved in endurance fitness. In addition, the protocol described here should be useful for assessing early-stage proof-of-concept interventions in preclinical models of muscle disuse atrophy.


Metabolism ◽  
2005 ◽  
Vol 54 (8) ◽  
pp. 1048-1055 ◽  
Author(s):  
Henriette Pilegaard ◽  
Takuya Osada ◽  
Lisbeth T. Andersen ◽  
Jørn W. Helge ◽  
Bengt Saltin ◽  
...  

2019 ◽  
Vol 33 (3) ◽  
pp. 4586-4597 ◽  
Author(s):  
Chris Mcglory ◽  
Stefan H. M. Gorissen ◽  
Michael Kamal ◽  
Ravninder Bahniwal ◽  
Amy J. Hector ◽  
...  

2020 ◽  
Vol 129 (1) ◽  
pp. 5-16 ◽  
Author(s):  
Erik D. Hanson ◽  
Andrew C. Betik ◽  
Cara A. Timpani ◽  
John Tarle ◽  
Xinmei Zhang ◽  
...  

Low testosterone levels during skeletal muscle disuse did not worsen declines in muscle mass and function, although hypogonadism may attenuate recovery during subsequent reloading. Diets high in casein did not improve outcomes during immobilization or reloading. Practical strategies are needed that do not compromise caloric intake yet provide effective protein doses to augment these adverse effects.


2014 ◽  
Vol 144 (8) ◽  
pp. 1196-1203 ◽  
Author(s):  
Marlou L. Dirks ◽  
Benjamin T. Wall ◽  
Rachel Nilwik ◽  
Daniëlle H.J.M. Weerts ◽  
Lex B. Verdijk ◽  
...  

2006 ◽  
Vol 38 (Supplement) ◽  
pp. S52-S53
Author(s):  
Krista Vandenborne ◽  
Chris M. Gregory ◽  
Glenn A. Walter ◽  
Rongye Shi ◽  
Mark T. Scarborough ◽  
...  

1982 ◽  
Vol 56 (4) ◽  
pp. 241-244 ◽  
Author(s):  
Ch. F. Lindboe ◽  
Ch. S. Platou

Sign in / Sign up

Export Citation Format

Share Document